Tumor cells and other tumor microenvironment (TME) cells, especially cancer-associated fibroblasts (CAF), produce collagen, which forms the majority of the tumor matrix and enhance the production of Lysyl oxidase (LOX), leading to collagen crosslinking, ECM rearrangement, and higher stiffness [22, 23]. The gene discussed is LOX; the disease is cancer.